Company intelligence / Profile preview

Biohit Oyj

Helsinki, Finlandbiohithealthcare.com ↗
Ownership
Public · BIOBV
Employees
~50
Development stage
Other
01

Overview

Biohit has a long commercial track record with CE-marked diagnostic products in global use. Its flagship products include the GastroPanel blood test for non-invasive diagnosis of stomach-related diseases, ColonView lateral flow tests for colorectal cancer screening, rapid tests for lactose intolerance/celiac/Helicobacter pylori infections, acetaldehyde-binding lozenges to reduce carcinogen exposure in the stomach/smoking cessation aid. Subsidiaries have developed COVID‑19 antigen/antibody rapid tests with international regulatory approvals.

Therapeutic areas
OtherGastroenterologyOncologyInfectious Diseases
Modalities
Monoclonal antibodiesImmunoassays/ELISA testsIn vitro diagnostics (IVD)Lateral flow assays
Industry
Protein Biomarker Diagnostics
02

Partnerships

Distribution network includes over forty distributors worldwide including Avrio Genetics/Bio Testing Supplies as US distributor.
03

Financials

Market cap
$36.7M
Total revenue
$17.5M
Enterprise value
$35M

Beyond the preview

Go deeper on Biohit Oyj.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biohit Oyj.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call